-

908 Devices to Report Third Quarter Financial Results on November 4, 2021

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the third quarter 2021 before market open on Thursday, November 4, 2021. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.908devices.com. The webcast will be archived and available for replay within 24 hours after the event.

About 908 Devices

908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation, and machine learning.

Contacts

Investor Contact
Carrie Mendivil
IR@908devices.com

Media Contact
Katie Johnston
PAN Communications for 908 Devices
908devices@pancomm.com

908 Devices Inc.

NASDAQ:MASS

Release Versions

Contacts

Investor Contact
Carrie Mendivil
IR@908devices.com

Media Contact
Katie Johnston
PAN Communications for 908 Devices
908devices@pancomm.com

More News From 908 Devices Inc.

908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended September 30, 2022. “We were pleased with our results for the third quarter as we continue to support our customers’ critical-to-life applications. We also executed the strategic acquisition of TRACE Analytics, which provides in-line testing of critical parameters in the bioreact...

908 Devices to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate in the following investor conferences in New York, NY. Stifel 2022 Healthcare Conference Fireside Chat on Wednesday, November 16th at 1:15 p.m. Eastern Time / 10:15 a.m. Pacific Time Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum Fireside Chat on Thursday, November...

908 Devices to Report Third Quarter 2022 Financial Results on November 14, 2022

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the third quarter 2022 before market open on Monday, November 14, 2022. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the compan...
Back to Newsroom